Scancell selects PharmaJet to deliver DNA-based Covid-19 vaccines

By NS Medical Staff Writer

15 Sep 21

PharmaJet Tropis and PharmaJet Stratis needle-free injection systems will be exclusively used to administer the vaccine candidates

DevicesDrug Delivery

Novocure’s TTFields delivery system granted FDA breakthrough device designation

By NS Medical Staff Writer

10 Sep 21

NovoTTF-200T, which is a a Tumor Treating Fields (TTFields) delivery system, is intended for use together with atezolizumab…

DevicesDrug Delivery

AFYX unveils positive study results for Rivelin Patch in treating mucosal diseases

By NS Medical Staff Writer

08 Sep 21

The preclinical study shows potential to deliver anti-TNFα antibody fragments to inflamed mucosal tissue using Rivelin technology

DevicesDrug Delivery

PharmaJet Partner Zydus Cadila Announces Emergency Use Authorisation Approval for World’s First Plasmid DNA Covid-19 Vaccine

By NS Medical Staff Writer

24 Aug 21

The vaccine, ZyCoV-D, is exclusively administered using the PharmaJet Tropis® Needle-free Injection System

DevicesDrug Delivery

Picocyl Expands Product Line and Production Capacity as Demand for Pico-Cylinders Soars

By NS Medical Staff Writer

11 Aug 21

As new and novel drug therapies are developed to address areas where conventional medicines are limited, drug delivery…

DevicesDrug Delivery

Berry Global to build new manufacturing facility in Bangalore, India

By NS Medical Staff Writer

06 Aug 21

The new facility will allow Berry Global to expand its R&D expertise and scale up production in various…

DevicesDrug Delivery

Aptar to buy Hengyu to expand in China

By NS Medical Staff Writer

29 Jul 21

Hengyu provides elastomeric and plastic components used in injectable drug delivery

DevicesDrug Delivery

Medtronic rolls out Prevail DCB catheter in Europe

By NS Medical Staff Writer

27 Jul 21

The Prevail DCB is designed to treat narrowed or blocked coronary arteries in patients with coronary artery disease

Diagnostic Devices

Aptar to buy stake in digital therapeutics developer Voluntis

By NS Medical Staff Writer

26 Jul 21

The company has agreed to acquire up to 64.6% share capital in Voluntis by paying €8.70 per share

DevicesDrug Delivery

Happify Launches First Prescription Digital Therapeutics to Treat Both MDD and GAD

By NS Medical Staff Writer

26 Jul 21

Ensemble is the first transdiagnostic PDT for MDD and GAD available in the US

DevicesDrug Delivery